Business
The U.K. authorizes AstraZeneca’s coronavirus vaccine for emergency supply
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
On Wednesday morning, the U.K. authorized AstraZeneca‘s (NASDAQ: AZN) coronavirus vaccine candidate for emergency supply. The first doses of COVID-19 Vaccine AstraZeneca (formerly known as AZD1222) will be released today with the intention to begin vaccinations early in the new year.
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) recommends two full doses given four to 12 weeks apart. This is the dosing regimen that appeared 62% effective in clinical trials in the U.K. and Brazil.
You may remember an unintentionally administered half-dose/full-dose regimen that appeared more than 90% effective in a…
-
Noosa News15 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General9 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Business14 hours agoWhere to invest $20,000 into ASX 200 shares after the market selloff
-
General11 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for